December 9, 2024
Researchers in the lab of Jen Jen Yeh, MD, have identified two kinotypes that differentiate the two established molecular subtypes pancreatic cancer, as reported in a paper published in Cancer Discovery.
December 2, 2024
Ryan and Brandon Mouery have always been together, including now at UNC Lineberger where they study ways to improve pancreatic cancer treatments.
November 21, 2024
Nurse navigators and nurse practitioners are crucial members of our team at the N.C. Basnight Cancer Hospital, UNC Lineberger’s clinical home.
October 15, 2024
The NIH has awarded a five-year, $2.79 million R01 research grant to Justin Milner, PhD, to define how a druggable family of epigenetic regulators control T cell activity.
October 7, 2024
Jonathan Serody, MD, and Jen Jen Yeh, MD, were named the 2023 recipients of the Hyman L. Battle Distinguished Cancer Research Award, recognizing their significant scientific achievements.
September 23, 2024
Naim Rashid, PhD, has received a Department of Defense Pancreatic Cancer Research Program pilot award to build an AI tool that generates personalized clinical trial recommendations for patients with PDAC.
August 6, 2024
A phase I gene therapy study at UNC Lineberger is now recruiting patients with refractory pancreatic ductal adenocarcinoma (PDAC) to test the safety and tolerability of escalating doses of iC9.CAR.B7-H3 T-cells.
July 2, 2024
NIH Director Monica Bertagnolli, MD, wrote about research led by UNC Lineberger’s Channing Der, PhD, and Adrienne Cox, PhD, that provided the most comprehensive molecular portrait of the workings of KRAS.
June 28, 2024
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
June 6, 2024
UNC Lineberger researchers have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene, and how its activities impact pancreatic cancer outcomes.
